Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Apoptosis

Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition

Abstract

inhibitors of proteases are currently emerging as a potential anti-cancer modality. nonselective protease inhibitors are cytotoxic to leukemia and cancer cell lines and we found that this cytotoxicity is correlated with their potency as inhibitors of the proteasome but not as inhibitors of calpain and cathepsin. highly selective inhibitors of the proteasome were more cytotoxic and fast-acting than less selective inhibitors (ps341>>alln>>allm). induction of wt p53 correlated with inhibition of the proteasome and antiproliferative effect in mcf-7, a breast cancer cell line, which was resistant to apoptosis caused by proteasome inhibitors. in contrast, inhibitors of the proteasome induced apoptosis in four leukemia cell lines lacking wt p53. the order of sensitivity of leukemia cells was: jurkat>hl60u937>>K562. The highly selective proteasome inhibitor PS-341 induced cell death with an IC50 as low as 5 nM in apoptosis-prone leukemia cells. Cell death was preceded by p21WAF1/CIP1 accumulation, an alternative marker of proteasome inhibition, and by cleavage of PARP and Rb proteins and nuclear fragmentation. Inhibition of caspases abrogated PARP cleavage and nuclear fragmentation and delayed, but did not completely prevent cell death caused by PS-341. Reintroduction of wt p53 into p53-null PC3 prostate carcinoma cells did not increase their sensitivity to proteasome inhibitors. Likewise, comparison of parental and p21-deficient cells demonstrated that p21WAF1/CIP1 was dispensable for proteasome inhibitor-induced cytotoxicity. We conclude that accumulation of wt p53 and induction of apoptosis are independent markers of proteasome inhibition.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Fisher DE . Apoptosis in cancer therapy: crossing the threshold Cell 1994 78: 539–542

    Article  CAS  Google Scholar 

  2. Kastan MB, Canman CE, Leonard CJ . P53, cell cycle control and apoptosis: implications for cancer Cancer Metastasis Rev 1995 14: 3–15

    Article  CAS  Google Scholar 

  3. Martin SJ, Green DR . Apoptosis as a goal of cancer therapy Curr Opin Oncol 1994 6: 616–621

    Article  CAS  Google Scholar 

  4. Hannun YA . Apoptosis and the dilemma of cancer chemotherapy Blood 1997 89: 1845–1853

    CAS  PubMed  Google Scholar 

  5. Samali A, Zhivotovsky B, Jones D, Nagata S, Orrenius S . Apoptosis: cell death defined by caspase activation Cell Death Differ 1999 6: 495–496

    Article  CAS  Google Scholar 

  6. Lin KI, Baraban JM, Ratan RR . Inhibition versus induction of apoptosis by proteasome inhibitors depends on concentration Cell Death Differ 1998 5: 577–583

    Article  CAS  Google Scholar 

  7. Piedimonte G, Crinelli R, Salda LD, Corsi D, Pennisi MG, Kramer L, Casabianca A, Sarli G, Bendinelli M, Marcato PS, Magnani M . Protein degradation and apoptotic death in lymphocytes during Fiv infection: activation of the ubiquitin-proteasome proteolytic system Exp Cell Res 1999 248: 381–390

    Article  CAS  Google Scholar 

  8. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A . Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha EMBO J 1996 15: 3861–3870

    Article  CAS  Google Scholar 

  9. Squier MK, Sehnert AJ, Sellins KS, Malkinson AM, Takano E, Cohen JJ . Calpain and calpastatin regulate neutrophil apoptosis J Cell Physiol 1999 178: 311–319

    Article  CAS  Google Scholar 

  10. Villa PG, Henzel WJ, Sensenbrenner M, Henderson CE, Pettmann B . Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis J Cell Sci 1998 111: 713–722

    CAS  PubMed  Google Scholar 

  11. Waterhouse NJ, Finucane DM, Green DR, Elce JS, Kumar S, Alnemri ES, Litwack G, Khanna K, Lavin MF, Watters DJ . Calpain activation is upstream of caspases in radiation-induced apoptosis Cell Death Differ 1998 5: 1051–1061

    Article  CAS  Google Scholar 

  12. Wood DE, Newcomb EW . Caspase-dependent activation of calpain during drug-induced apoptosis J Biol Chem 1999 274: 8309–8315

    Article  CAS  Google Scholar 

  13. Wu GS, Saftig P, Peters C, El-Deiry WS . Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity Oncogene 1998 16: 2177–2183

    Article  CAS  Google Scholar 

  14. Grassilli E, Benatti F, Dansi P, Giammarioli AM, Malorni W, Franceschi C, Desiderio MA . Inhibition of proteasome function prevents thymocyte apoptosis: involvement of ornithine decarboxylase Biochem Biophys Res Commun 1998 250: 293–297

    Article  CAS  Google Scholar 

  15. Shinohara K, Tomioka M, Nakano H, Tone S, Ito H, Kawashima S . Apoptosis induction resulting from proteasome inhibition Biochem J 1996 317: 385–388

    Article  CAS  Google Scholar 

  16. Lopes UG, Erhardt P, Yao R, Cooper GM . p53-dependent induction of apoptosis by proteasome inhibitors J Biol Chem 1997 272: 12893–12896

    Article  CAS  Google Scholar 

  17. Drexler HC . Activation of the cell death program by inhibition of proteasome function Proc Natl Acad Sci USA 1997 94: 855–860

    Article  CAS  Google Scholar 

  18. An B, Goldfarb RH, Siman R, Dou QP . Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts Cell Death Differ 1998 5: 1062–1075

    Article  CAS  Google Scholar 

  19. Chandra J, Niemer I, Gilbreath J, Kliche KO, Andreeff M, Freireich EJ, Keating M, McConkey DJ . Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes Blood 1998 92: 4220–4229

    CAS  PubMed  Google Scholar 

  20. Orlowski RZ . The role of the ubiquitin-proteasome pathway in apoptosis Cell Death Differ 1999 6: 303–313

    Article  CAS  Google Scholar 

  21. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ . Proteasome inhibitors: a novel class of potent and effective antitumor agents Cancer Res 1999 59: 2615–2622

    CAS  PubMed  Google Scholar 

  22. Fenteany G, Schreiber SL . Lactacystin, proteasome function, and cell fate J Biol Chem 1998 273: 8545–8548

    Article  CAS  Google Scholar 

  23. Zhang XM, Lin H, Chen C, Chen BD . Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells Biochem J 1999 340: 127–133

    Article  CAS  Google Scholar 

  24. Wagenknecht B, Hermisson M, Eitel K, Weller M . Proteasome inhibitors induce p53/p21-independent apoptosis in humanglioma cells Cell Physiol Biochem 1999 9: 117–125

    Article  CAS  Google Scholar 

  25. Gottlieb TM, Oren M . p53 and apoptosis Semin Cancer Biol 1998 8: 359–368

    Article  CAS  Google Scholar 

  26. Katayose Y, Kim M, Rakkar AN, Li Z, Cowan KH, Seth P . Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27 Cancer Res 1997 57: 5441–5445

    CAS  PubMed  Google Scholar 

  27. Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA . Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1 Cell 1999 97: 575–586

    Article  CAS  Google Scholar 

  28. Ciechanover A . The ubiquitin-proteasome proteolytic pathway Cell 1994 79: 13–21

    Article  CAS  Google Scholar 

  29. Alessandrini A, Chiaur DS, Pagano M . Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation Leukemia 1997 11: 342–345

    Article  CAS  Google Scholar 

  30. Blagosklonny MV, An WG, Melillo G, Nguyen P, Trepel J, Neckers L . Regulation of BRCA1 by protein degradation Oncogene 1999 18: 6460–6468

    Article  CAS  Google Scholar 

  31. Maki CG, Huibregtse JM, Howley PM . In vivo ubiquitination and proteasome-mediated degradation of p53 Cancer Res 1996 56: 2649–2654

    CAS  Google Scholar 

  32. Blagosklonny MV, Wu GS, Omura S, El-Deiry WS . Proteasome-dependent regulation of p21WAF1/CIP1 expression Biochem Biophys Res Commun 1996 227: 564–569

    Article  CAS  Google Scholar 

  33. Dietrich C, Bartsch T, Schanz F, Oesch F, Wieser RJ . p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblast Proc Natl Acad Sci USA 1996 93: 10815–10819

    Article  CAS  Google Scholar 

  34. Kubbutat MH, Vousden KH . Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability Mol Cell Biol 1997 17: 460–468

    Article  CAS  Google Scholar 

  35. Gonen H, Shkedy D, Barnoy S, Kosower NS, Ciechanover A . On the involvement of calpains in the degradation of the tumor suppressor protein p53 FEBS Lett 1997 406: 17–22

    Article  CAS  Google Scholar 

  36. Salvat C, Aquaviva C, Jariel-Encontre I, Ferrara P, Pariat M, Steff AM, Carillo S, Piechaczyk M . Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? Mol Biol Rep 1999 26: 45–51

    Article  CAS  Google Scholar 

  37. Waldman T, Kinzler KW, Vogelstein B . p21 is necessary for the p53-mediated G1 arrest in human cancer cells Cancer Res 1995 55: 5187–5190

    CAS  PubMed  Google Scholar 

  38. Blagosklonny MV, Somasundaram K, Wu GS, El-Deiry WS . Wild-type p53 is not sufficient for serum starvation-induced apoptosis in cancer cells but accelerates apoptosis in sensitive cells Int J Oncol 1997 11: 1165–1170

    CAS  PubMed  Google Scholar 

  39. Blagosklonny MV, Chuman Y, Bergan RC, Fojo T . Mitogen activated protein kinase pathways is dispensible for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells Leukemia 1999 13: 1028–1036

    Article  CAS  Google Scholar 

  40. Blagosklonny MV . Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal Leukemia 1999 13: 2031–2035

    Article  CAS  Google Scholar 

  41. Choi YH, Lee SJ, Nguyen P, Jang JS, Lee J, Wu ML, Takano E, Maki M, Henkart PA, Trepel JB . Regulation of cyclin D1 by calpain protease J Biol Chem 1997 272: 28479–28484

    Article  CAS  Google Scholar 

  42. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Coldberg AL . Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules Cell 1994 78: 761–771

    Article  CAS  Google Scholar 

  43. Wang KK, Nath R, Posner A, Raser KJ, Buroker-Kilgore M, Hajimohammadreza I, Probert AW Jr, Marcoux FW, Ye Q, Takano E, Hatanaka M, Maki M, Caner H, Collins JL, Fergus A, Lee KS, Lunney EA, Hays SJ, Yuen P . An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective Proc Natl Acad Sci USA 1996 93: 6687–6692

    Article  CAS  Google Scholar 

  44. Whitesell L, Sutphin P, An WG, Schulte T, Blagosklonny MV, Neckers L . Geldanamycin-stimulated destabolization of mutated p53 is mediated by the proteasome in vivo Oncogene 1997 14: 2809–2816

    Article  CAS  Google Scholar 

  45. Pan Y, Haines DS . The pathway regulating MDM2 protein degradation can be altered in human leukemic cells Cancer Res 1999 59: 2064–2067

    CAS  PubMed  Google Scholar 

  46. Laumann R, Jucker M, Tesch H . Point mutations in the conserved regions of the p53 tumor suppressor gene do not account for the transforming process in the Jurkat acute lymphoblastic leukemia T cells Leukemia 1992 6: 227–228

    CAS  PubMed  Google Scholar 

  47. Bhalla K, Ibrado AM, Tourkina E, Tang C, Maloney ME, Huang Y . Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells Leukemia 1993 7: 563–568

    CAS  PubMed  Google Scholar 

  48. Bullock G, Ray S, Reed JC, Krajewski S, Ibrado AM, Huang Y, Bhalla K . Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein Leukemia 1996 10: 1731–1740

    CAS  PubMed  Google Scholar 

  49. McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TM . Bcr-Abl maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death Blood 1994 83: 1179–1187

    CAS  PubMed  Google Scholar 

  50. Martins LM, Mesner PW, Kottke TJ, Basi GS, Sinha S, Tung JS, Svingen PA, Madden BJ, Takahashi A, McCormick DJ, Earnshaw WC, Kaufmann SH . Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis Blood 1997 90: 4283–4296

    CAS  PubMed  Google Scholar 

  51. Dubrez L, Eymin B, Sordet O, Droin N, Turhan AG, Solary E . BCR-ABL delays apoptosis upstream of procaspase-3 activation Blood 1998 91: 2415–2422

    CAS  PubMed  Google Scholar 

  52. Amarante-Mendes GP, Naekyung Kim C, Liu L, Huang Y, Perkins CL, Green DR, Bhalla K . Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3 Blood 1998 91: 1700–1705

    CAS  PubMed  Google Scholar 

  53. Blagosklonny MV, El-Deiry WS . In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug Int J Cancer 1996 67: 386–392

    Article  CAS  Google Scholar 

  54. Katayose D, Gudas J, Nguyen H, Srivastava S, Cowan KH, Seth P . Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells Clin Cancer Res 1995 1: 889–897

    CAS  PubMed  Google Scholar 

  55. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B . Genetic determinants of p53-induced apoptosis and growth arrest Genes Dev 1996 10: 1945–1952

    Article  CAS  Google Scholar 

  56. Herrmann JL, Briones FJ, Brisbay S, Logothetis CJ, McDonnell TJ . Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53 Oncogene 1998 17: 2889–2899

    Article  CAS  Google Scholar 

  57. Freemerman AJ, Vrana JA, Tombes RM, Jiang H, Chellappan SP, Fisher PB, Grant S . Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation in human myeloid leukemia cells (HL-60) Leukemia 1997 11: 504–513

    Article  CAS  Google Scholar 

  58. Glockzin S, von Knethen A, Scheffner M, Brne B . Activation of the cell death program by nitric oxide involves inhibition of the proteasome J Biol Chem 1999 274: 19581–19586

    Article  CAS  Google Scholar 

  59. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M . Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science 1995 269: 682–685

    Article  CAS  Google Scholar 

  60. Urano T, Yashiroda H, Muraoka M, Tanaka K, Hosoi T, Inoue S, Ouchi Y, Toyoshima H . p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor betal J Biol Chem 1999 274: 12197–12200

    Article  CAS  Google Scholar 

  61. Antoku K, Liu Z, Johnson DE . Inhibition of caspase proteases by CrmA enhances the resistance of human leukemic cells to multiple chemotherapeutic agents Leukemia 1997 11: 1665–1672

    Article  CAS  Google Scholar 

  62. Classen CF, Fulda S, Friesen C, Debatin KM . Decreased sensitivity of drug-resistant cells towards T cell cytotoxicity Leukemia 1999 13: 410–418

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

An, W., Hwang, SG., Trepel, J. et al. Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition. Leukemia 14, 1276–1283 (2000). https://doi.org/10.1038/sj.leu.2401812

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401812

Keywords

This article is cited by

Search

Quick links